Constitutional Mismatch Repair Deficiency Syndrome
📧 Sign up to get email alerts when something new happens for Constitutional Mismatch Repair Deficiency Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma [Phase 1]
Phase 1 trial of pembrolizumab in pediatric patients with recurrent or refractory high-grade gliomas, including diffuse intrinsic pontine gl…
-
CLINICAL_TRIALS withdrawal · 2025-09-10Clinical Trial Update: Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study [Phase 1]
This document reports the withdrawal of a Phase 1 trial evaluating the combination of nivolumab and ipilimumab in pediatric and young adult …